SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) remains a lethal disease despite many proposed treatments. Recent studies have indicated that epigenetic therapy, which targets epigenetic effects, might be a new therapeutic methodology for NSCLC. However, it is not clear which objects (e.g., genes) th...

Descripción completa

Detalles Bibliográficos
Autores principales: Taguchi, Y-h., Iwadate, Mitsuo, Umeyama, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989892/
https://www.ncbi.nlm.nih.gov/pubmed/27534621
http://dx.doi.org/10.1186/s12920-016-0196-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989892/
https://www.ncbi.nlm.nih.gov/pubmed/27534621
http://dx.doi.org/10.1186/s12920-016-0196-3

Ejemplares similares